Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thales C Nepomuceno

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancers|April 25, 2019
Germline Missense Variants in <i>BRCA1</i>: New Trends and Challenges for Clinical AnnotationVolha A Golubeva, Thales C Nepomuceno, Alvaro N A Monteiro
Trends in Cancer|November 3, 2020
PALB2 Variants: Protein Domains and Cancer SusceptibilityThales C Nepomuceno, Marcelo A Carvalho, Amélie Rodrigue, et al.
International Journal of Molecular Sciences|September 1, 2017
The Role of PALB2 in the DNA Damage Response and Cancer PredispositionThales C Nepomuceno, Giuliana De Gregoriis, Francisco M Bastos de Oliveira, et al.
Iscience|November 21, 2024
SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localizationSamuele Lodovichi, Thales C Nepomuceno, Nicholas T Woods, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2017
BRCA1 recruitment to damaged DNA sites is dependent on CDK9Thales C Nepomuceno, Vanessa C Fernandes, Thiago T Gomes, et al.
Cancer Biology & Therapy|April 24, 2014
Characterization of LGALS3 (galectin-3) as a player in DNA damage responseRenato S Carvalho, Vanessa C Fernandes, Thales C Nepomuceno, et al.
The Journal of Biological Chemistry|October 2, 2022
Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancerOu Deng, Sweta Dash, Thales C Nepomuceno, et al.
Frontiers in Pharmacology|July 15, 2022
Functional Restoration of <i>BRCA1</i> Nonsense Mutations by Aminoglycoside-Induced ReadthroughRenata B V Abreu, Thiago T Gomes, Thales C Nepomuceno, et al.
European Journal of Human Genetics : EJHG|November 22, 2021
Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locusGustavo Mendoza-Fandiño, Paulo Cilas M Lyra, Thales C Nepomuceno, et al.
JCO Clinical Cancer Informatics|May 6, 2024
Assessment of <i>BRCA1</i> and <i>BRCA2</i> Germline Variant Data From Patients With Breast Cancer in a Real-World Data RegistryThales C Nepomuceno, Paulo Lyra, Jianbin Zhu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancers|April 25, 2019
Germline Missense Variants in <i>BRCA1</i>: New Trends and Challenges for Clinical AnnotationVolha A Golubeva, Thales C Nepomuceno, Alvaro N A Monteiro
Trends in Cancer|November 3, 2020
PALB2 Variants: Protein Domains and Cancer SusceptibilityThales C Nepomuceno, Marcelo A Carvalho, Amélie Rodrigue, et al.
International Journal of Molecular Sciences|September 1, 2017
The Role of PALB2 in the DNA Damage Response and Cancer PredispositionThales C Nepomuceno, Giuliana De Gregoriis, Francisco M Bastos de Oliveira, et al.
Iscience|November 21, 2024
SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localizationSamuele Lodovichi, Thales C Nepomuceno, Nicholas T Woods, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2017
BRCA1 recruitment to damaged DNA sites is dependent on CDK9Thales C Nepomuceno, Vanessa C Fernandes, Thiago T Gomes, et al.
Cancer Biology & Therapy|April 24, 2014
Characterization of LGALS3 (galectin-3) as a player in DNA damage responseRenato S Carvalho, Vanessa C Fernandes, Thales C Nepomuceno, et al.
The Journal of Biological Chemistry|October 2, 2022
Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancerOu Deng, Sweta Dash, Thales C Nepomuceno, et al.
Frontiers in Pharmacology|July 15, 2022
Functional Restoration of <i>BRCA1</i> Nonsense Mutations by Aminoglycoside-Induced ReadthroughRenata B V Abreu, Thiago T Gomes, Thales C Nepomuceno, et al.
European Journal of Human Genetics : EJHG|November 22, 2021
Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locusGustavo Mendoza-Fandiño, Paulo Cilas M Lyra, Thales C Nepomuceno, et al.
JCO Clinical Cancer Informatics|May 6, 2024
Assessment of <i>BRCA1</i> and <i>BRCA2</i> Germline Variant Data From Patients With Breast Cancer in a Real-World Data RegistryThales C Nepomuceno, Paulo Lyra, Jianbin Zhu, et al.
Pageof 2